Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Semaglutide Pharmacokinetics in Healthy Subjects, Effect of Dosing Schedules

NCT04513704 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04513704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Semaglutide Pharmacokinetics in Healthy Subjects, Effect of Dosing Schedules
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Completed
Start date
August 28, 2020
Completion date
May 26, 2021
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers type 2 diabetes